Münci Yağcı

2.4k total citations
86 papers, 779 citations indexed

About

Münci Yağcı is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, Münci Yağcı has authored 86 papers receiving a total of 779 indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Hematology, 29 papers in Genetics and 29 papers in Oncology. Recurrent topics in Münci Yağcı's work include Multiple Myeloma Research and Treatments (24 papers), Chronic Lymphocytic Leukemia Research (14 papers) and Lymphoma Diagnosis and Treatment (11 papers). Münci Yağcı is often cited by papers focused on Multiple Myeloma Research and Treatments (24 papers), Chronic Lymphocytic Leukemia Research (14 papers) and Lymphoma Diagnosis and Treatment (11 papers). Münci Yağcı collaborates with scholars based in Türkiye, United States and Spain. Münci Yağcı's co-authors include Gülsan Türköz Sucak, Zübeyde Nur Özkurt, Şahika Zeynep Akı, Rauf Haznedar, Zeynep Arzu Yeğin, Elif Suyanı, Nalân Akyürek, Kadir Acar, Ümit Özgür Akdemir and Özlem Güzel Tunçcan and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and European Journal of Nuclear Medicine and Molecular Imaging.

In The Last Decade

Münci Yağcı

78 papers receiving 768 citations

Peers

Countries citing papers authored by Münci Yağcı

Since Specialization

Citations

This map shows the geographic impact of Münci Yağcı's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Münci Yağcı with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Münci Yağcı more than expected).

Fields of papers citing papers by Münci Yağcı

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Münci Yağcı. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Münci Yağcı. The network helps show where Münci Yağcı may publish in the future.

Co-authorship network of co-authors of Münci Yağcı

This figure shows the co-authorship network connecting the top 25 collaborators of Münci Yağcı. A scholar is included among the top collaborators of Münci Yağcı based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Münci Yağcı. Münci Yağcı is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Phase 3 trial evaluating the efficacy and safety of odronextamab versus investigator’s choice in previously untreated follicular lymphoma (OLYMPIA-1). 2024 ·Journal of Clinical Oncology ·Ruemu Birhiray, Stefano Luminari, Tae Min Kim, Münci Yağcı, Timothy R. Wassenaar, (unknown), (unknown), (unknown), (unknown), Min Zhu, Sushmita Mukherjee, Jurriaan Brouwer‐Visser, Aafia Chaudhry, Hesham Mohamed, Srikanth Ambati, Umberto Vitolo	2
2	Comparison of the Results of Galactomannan and Beta Glucan Antigen Tests in the Suspicion of Invasive Pulmonary Aspergillosis 2023 ·Mikrobiyoloji Bulteni ·(unknown), Ayşe Kalkancı, Özlem Güzel Tunçcan, Zeynep Arzu Yeğin, Zübeyde Nur Özkurt, Nurdan Köktürk, Münci Yağcı	1
3	Clinical factors associated with autologous stem cell transplantation outcomes in multiple myeloma: upfront transplant with MEL200 remains the standard of care 2023 ·Annals of Hematology ·(unknown), Zeynep Arzu Yeğin, Ümit Özgür Akdemir, (unknown), (unknown), Zübeyde Nur Özkurt, Lütfiye Özlem Atay, Münci Yağcı	0
4	Is flow cytometry useful in determining central nervous system involvement in patients with hematological malignancy? Analysis with a prospective cohort 2023 ·Leukemia Research ·(unknown), Zübeyde Nur Özkurt, (unknown), Zeynep Arzu Yeğin, (unknown), Nalân Akyürek, Münci Yağcı	2
5	Comparison of daily oral iron replacement therapy with every other day treatment in female reproductive age patients with iron-deficiency anemia 2022 ·Annals of Hematology ·(unknown), (unknown), (unknown), Zeynep Arzu Yeğin, Zübeyde Nur Özkurt, Münci Yağcı	3
6	Successful Treatment of Refractory Uterine Bleeding in a Female Patient with Type 3 Von Willebrand Disease and Inhibitor 2022 ·The Journal of Obstetrics and Gynecology of India ·(unknown), Zühre Kaya, (unknown), (unknown), (unknown), Münci Yağcı	1
7	Infections in hematopoietic stem cell transplant patients admitted to Hematology intensive care unit: a single-center study 2021 ·Hematology ·(unknown), (unknown), Gülbin Aygencel, Melda Türkoğlu, Özlem Güzel Tunçcan, (unknown), (unknown), Zübeyde Nur Özkurt, Zeynep Arzu Yeğin, Münci Yağcı	9
8	Easier and more explanatory indices by integrating leukocyte lymphocyte ratio (LLR) and prognostic nutritional index (PNI) to IPS systems in cases with classical Hodgkin lymphoma 2021 ·Leukemia Research ·Semra Paydaş, Şahin Laçin, Mutlu Doğan, İbrahim Barışta, (unknown), Gülşah Şeydaoğlu, Nuri Karadurmuş, (unknown), Kaplan Ma, Münci Yağcı, (unknown), (unknown)	9
9	IPS-3 Validation in 1012 cases with classical hodgkin lymphoma 2021 ·Leukemia Research ·Semra Paydaş, Şahin Laçin, Mutlu Doğan, İbrahim Barışta, (unknown), Gülşah Şeydaoğlu, Nuri Karadurmuş, (unknown), Kaplan Ma, Münci Yağcı, Emel Gürkan, (unknown)	1
10	The Impact of Pre-transplant Cell-free DNA Levels on Leukemia Relapse and Transplant-related Complications in Allogeneic Hematopoietic Stem Cell Transplant Recipients 2020 ·Balkan Medical Journal ·Zeynep Arzu Yeğin, (unknown), (unknown), (unknown), Zübeyde Nur Özkurt, (unknown), Münci Yağcı	5
11	Comparison of Post-Remission Strategies in Acute Myeloid Leukemia: Autologous Hematopoietic Stem Cell Transplantation versus Consolidation Chemotherapy 2020 ·SHILAP Revista de lepidopterología ·Zeynep Arzu Yeğin, (unknown), (unknown), (unknown), (unknown), Münci Yağcı	2
12	Long-term results of brentuximab vedotin in relapsed and refractory Hodgkin lymphoma: multi-center real-life experience 2019 ·Annals of Hematology ·(unknown), Ayşe Salihoğlu, Teoman Soysal, Ìhsan Karadoǧan, Semra Paydaş, Evren Özdemir, (unknown), Nuri Karadurmuş, Leylagül Kaynar, Münci Yağcı, Vildan Özkocaman, (unknown), Muhıt Özcan, (unknown), Hakan Göker, Burhan Ferhanoğlu	5
13	Effects of Electroporation on Tamoxifen Delivery in Estrogen Receptor Positive (ER+) Human Breast Carcinoma Cells 2016 ·Cell Biochemistry and Biophysics ·(unknown), (unknown), Münci Yağcı, (unknown), (unknown)	5
14	Effects of Rat Bone Marrow–Derived Mesenchymal Stem Cells and Demineralized Bone Matrix on Cranial Bone Healing 2016 ·Annals of Plastic Surgery ·(unknown), Selahattin Özmen, (unknown), Münci Yağcı, (unknown), Çiğdem Elmas, Mehmet Araç, (unknown)	6
15	Evaluation of Multiple Myeloma Patients Presenting with Renal Failure in a University Hospital in the Year 2010 2012 ·Renal Failure ·Elif Suyanı, Gülsan Türköz Sucak, Yasemin Erten, Merih Kızıl Çakar, (unknown), Münci Yağcı, Rauf Haznedar	1
16	Early post-transplantation positron emission tomography in patients with Hodgkin lymphoma is an independent prognostic factor with an impact on overall survival 2011 ·Annals of Hematology ·Gülsan Türköz Sucak, Zübeyde Nur Özkurt, (unknown), (unknown), Ümit Özgür Akdemir, Şahika Zeynep Akı, Zeynep Arzu Yeğin, Münci Yağcı, Lütfiye Özlem Atay	28
17	High ferritin levels are associated with hepatosplenic candidiasis in hematopoietic stem cell transplant candidates 2010 ·International Journal of Infectious Diseases ·Özlem Güzel Tunçcan, Zeynep Arzu Yeğin, Zübeyde Nur Özkurt, Gonca Erbaş, Şahika Zeynep Akı, Esin Şenol, Münci Yağcı, Gülsan Türköz Sucak	14
18	Allogeneic stem cell transplantation for severe aplastic anemia: Graft rejection remains a problem 2009 ·Transfusion and Apheresis Science ·Şahika Zeynep Akı, Gülsan Türköz Sucak, Zübeyde Nur Özkurt, Zeynep Arzu Yeğin, Münci Yağcı, Rauf Haznedar	3
19	Thrombopoietic Cytokine and P-Selectin Levels in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation: Decrease in Posttransplantation P-Selectin Levels Might Predict the Degree of Maximum Response 2009 ·Clinical Lymphoma & Myeloma ·Şahika Zeynep Akı, Gülsan Türköz Sucak, Hatîce Paşaoğlu, Zübeyde Nur Özkurt, Zeynep Arzu Yeğin, Ebru Ofluoğlu, Münci Yağcı, Rauf Haznedar	6
20	Therapy-related refractory anemia with ringed sideroblasts in chronic lymphocytic leukemia 2001 ·Cancer Genetics and Cytogenetics ·Münci Yağcı, Gülsan Türköz Sucak, Gönül Oğur, Rauf Haznedar	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact